Target intelligence / Profile preview

Plasmodium falciparum heme (Fe(III)-PPIX) (Fe(III)-PPIX)

Target
Fe(III)-PPIX
Molecular classification
Metalloporphyrin, Metabolic byproduct, Prosthetic group
01

Overview

Plasmodium falciparum heme, specifically ferriprotoporphyrin IX (Fe(III)PPIX), is a toxic byproduct generated during the digestion of host hemoglobin within the parasite's acidic food vacuole (Egan, 2008). Because free heme is redox-active and can cause extensive membrane damage and oxidative stress, the parasite must detoxify it by sequestering it into chemically inert crystals known as hemozoin or malaria pigment (Sullivan, 2002). This detoxification process is a critical vulnerability in the parasite's life cycle and serves as the primary target for several classes of antimalarial drugs (Hempelmann, 2007). Quinolines, such as chloroquine and quinine, bind to heme or the surface of growing hemozoin crystals to prevent further polymerization, resulting in the accumulation of toxic heme that kills the parasite (Egan, 2008). Additionally, artemisinin-based compounds are activated by heme, leading to the production of free radicals that damage parasite proteins and lipids (Tilley et al., 2016).

Other names
Ferriprotoporphyrin IXHeminFree hemeMalaria pigment precursorHemozoin precursor
02

Mechanism of action

Inhibition of heme biocrystallization into hemozoin and formation of toxic drug-heme complexes (Egan, 2008; Sullivan, 2002).

03

Biological functions

Hemoglobin catabolismOxidative stress inductionBiocrystallization substrate
04

Disease associations

InfectionMalaria
05

Safety considerations

Drug resistance mediated by PfCRT mutationsTherapeutic challenges in targeting metabolic byproducts
06

Interacting drugs

Chloroquine

7 more in the full profile.

07

Biomarkers

HemozoinParasitemia

Beyond the preview

Go deeper on Plasmodium falciparum heme (Fe(III)-PPIX) (Fe(III)-PPIX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum heme (Fe(III)-PPIX) (Fe(III)-PPIX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call